SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CLTR COULTER PHARMACEUTICAL
An SI Board Since January 1997
Posts SubjectMarks Bans Symbol
666 17 0 CLTR
Emcee:  HARRY GIBSON Type:  Unmoderated
Introduction Market Data Compact
Just out of the gate. Anyone have any information?
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
666Adding this post to make sure that this thread (dormant since CRXA acquired CoulRCMac-7/3/2002
665Spek, I have reserved judgement on Melacine. I think Bex has $500m potential andVector1-1/6/2001
664V1 what do you think is the market potential for Bexxar? After the merger with CSpekulatius-1/6/2001
663Amgen Licenses Late-Stage Lymphoma Therapeutic From Immunomedics THOUSANscaram(o)uche-12/18/2000
662Perhaps the lack of favorable stock movement for CLTR is because Rituxan has proGary L. Kepler-12/6/2000
661Brian,Nigel and Gary, This is an excerpt from reuters tonight. -----------------Vector1-12/5/2000
660Perhaps there will be a delayed market reaction to CLTR news? CLTR did not resGary L. Kepler-12/5/2000
659Dec. 5, 2000-- IDEC Pharmaceuticals Corporation (Nasdaq:IDPH - news) announced tnigel bates-12/5/2000
658<i>IMO blows Zev away which was under 50% ORR with zero CR.</i> AndMicawber-12/5/2000
657Nigel <<produced a 70 percent overall response rate and a 40 percent complVector1-12/4/2000
656biz.yahoo.com Dec. 4, 2000-- Integrated Analyses of 251 Patients Treated with Bnigel bates-12/4/2000
655HALEHLUHLAH V1Vector1-11/14/2000
654I believe some number of you may have been awaiting this: Tuesday November 14, Micawber-11/14/2000
653Very interesting on invitro activity of BEX v Rit. Unlabeled Bex seems to be morVector1-11/12/2000
652SORRY THIS IS A REPEAT Data from just published abstracts t be presented at ASHVector1-11/12/2000
651Great data from just published abstracts t be presented at ASH. Bex shows strongVector1-11/12/2000
650My shares went up for sale a few days ago between 43 and 44. I liked the reasonHarold Engstrom-11/9/2000
649<<anybody heard anything? >> Not a thing V1Vector1-11/9/2000
648The widening of the CRXA/CLTR spread yesterday may be telling us somebody thinkstom pope-11/8/2000
647I can't find any news, but the action in CLTR/CRXA today looks like a good dtom pope-11/7/2000
646Jason, no question CRXA is pulling CLTR up. WIthout the deal the stock is in theVector1-11/6/2000
645V1, I agree, but I also think it's close to $45 instead of close to $35 becatnsaf-11/5/2000
644Jason, Nov. 15, 60 days from the resubmission fast approaching. Acceptance of thVector1-11/5/2000
643It's being dragged up, kicking and screaming, by CRXA. Jasontnsaf-11/2/2000
642CLTR breaking out...??? $40.5 volume is pretty good already this a.m. 217,00 Howard Bennett-11/2/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News